Bivalent Poliomyelitis Vaccine Live 10 dose vial (with a suitable dropper) Tender

Procurement Summary

Country : Sri Lanka

Summary : Bivalent Poliomyelitis Vaccine Live 10 dose vial (with a suitable dropper)

Deadline : 30 Apr 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 116428950

Document Ref. No. : DHS/P/WW/341/26

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Bivalent Poliomyelitis Vaccine Live 10
dose vial (with a suitable dropper)
Bivalent Poliomyelitis Vaccine Live Oral
(bOPV)10 dose vial Bivalent Poliomyelitis
Vaccine Live BP, EP or USP Liquid stabilized
preparation of live attenuated poliomyelitis
virus of the Sabin strains type 1 and type 3.
Each immunizing dose of vaccine should
contain not less than 10 6 TCID50 for type 1
and 10 5.8 TCID50 for type 3 (should
conform to the formulation of ratio of 10:6 for
vaccine virus sero type 1 and 3
respectively). One immunizing dose should
be contained preferably in two drops.
i.Offers should be only from vaccine
suppliers recommended by World Health
Organization (WHO) for bulk purchase for
the U.N. Agencies.
ii.The product should be from fresh stocks
and each consignment should be prepared
preferably from a single batch. Each batch
should accompany a certificate of
analysis, lot release certificate issued by
laboratory accredited by National Control
Authority and Summary Protocol of vaccine
production and quality control test data
should be submitted for protocol review.
iii.Each consignment should have a minimu
m remaining shelf life of 75% at the time of r
eceiving the consignment at MSD.
iv.The vaccine should also comply with the
general requirements for vaccines in the
BP, EP or USP.
v.The vaccine should meet the most recent
requirements of WHO when tested by the
methods outlined by WHO.
vi.Cold chain monitors or WHO
recommended other cold chain monitoring
device should be included in each pack
during delivery and the cold chain should be
maintained during storage, transport and
delivery of vaccines.
vii.The vaccine should be protected from
light and should be stored at a temperature -
20'C.
65, 000 vials 35, 000 vials/
August 2026
30, 000 Vials/
November 2026
2
viii.Each vial should be labeled accordingly
indicating both date of manufacture and
expiry.
ix.Must be a WHO prequalified product.
x.Each vial should be provided with a
suitable dropper.
xi.Each vial should contain a suitable
vaccine vial monitor.
xii.Chief Epidemiologist should be informed
two weeks prior to the arrival of vaccine

Documents

 Tender Notice